SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19 | -34.5% | 160 | -37.3% | 0.01% | -36.4% |
Q2 2023 | $29 | -17.1% | 255 | 0.0% | 0.01% | -15.4% |
Q1 2023 | $35 | +6.1% | 255 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $33 | -99.9% | 255 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $28,000 | +47.4% | 255 | 0.0% | 0.01% | +62.5% |
Q2 2022 | $19,000 | -5.0% | 255 | 0.0% | 0.01% | +14.3% |
Q1 2022 | $20,000 | -42.9% | 255 | -33.8% | 0.01% | -41.7% |
Q4 2021 | $35,000 | -7.9% | 385 | -7.2% | 0.01% | -20.0% |
Q3 2021 | $38,000 | +22.6% | 415 | +5.1% | 0.02% | +25.0% |
Q2 2021 | $31,000 | -71.0% | 395 | -72.6% | 0.01% | -77.8% |
Q1 2021 | $107,000 | +5.9% | 1,440 | +144.1% | 0.05% | 0.0% |
Q4 2020 | $101,000 | +14.8% | 590 | -5.6% | 0.05% | +3.8% |
Q3 2020 | $88,000 | -3.3% | 625 | +10.6% | 0.05% | -13.3% |
Q2 2020 | $91,000 | +9.6% | 565 | -33.5% | 0.06% | -18.9% |
Q1 2020 | $83,000 | +80.4% | 850 | +136.1% | 0.07% | +117.6% |
Q4 2019 | $46,000 | +31.4% | 360 | -22.6% | 0.03% | +25.9% |
Q3 2019 | $35,000 | -40.7% | 465 | +20.8% | 0.03% | -42.6% |
Q2 2019 | $59,000 | +7.3% | 385 | -16.3% | 0.05% | 0.0% |
Q1 2019 | $55,000 | – | 460 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |